Real-World Patient Experience of CGRP-Targeting Therapy for Migraine: a Narrative Review

被引：0
|
作者：
Ann M. Murray
Jennifer I. Stern
Carrie E. Robertson
Chia-Chun Chiang
机构：
[1] Mayo Clinic,Department of Neurology
来源：
Current Pain and Headache Reports | 2022年 / 26卷
关键词：
Real-world studies; CGRP; Monoclonal antibody; CGRP receptor antagonist; Medication overuse; Chronic migraine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：783 / 794
页数：11
相关论文
共 50 条
  • [21] Real-world experience of galcanezumab in the prevention of migraine in Spain: a systematic literature review
    Pozo-Rosich, Patricia
    Garcia-Azorin, David
    Diaz-Cerezo, Silvia
    Fernandez-Montoya, Julia
    de Paz, Hector David
    Nunez, Mercedes
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [22] Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
    Andrew M. Blumenfeld
    Benjamin M. Frishberg
    Jack D. Schim
    Ashley Iannone
    Gary Schneider
    Larisa Yedigarova
    Aubrey Manack Adams
    Pain and Therapy, 2021, 10 : 809 - 826
  • [23] Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
    Blumenfeld, Andrew M.
    Frishberg, Benjamin M.
    Schim, Jack D.
    Iannone, Ashley
    Schneider, Gary
    Yedigarova, Larisa
    Manack Adams, Aubrey
    PAIN AND THERAPY, 2021, 10 (02) : 809 - 826
  • [24] Real-world patient perspective on the burden and impact of migraine
    de la Torre, Elena Ruiz
    Martelletti, Paolo
    Craven, Audrey
    Walsh, Donna
    Evans, Simon
    Dumas, Paula
    Diener, Hans-Christoph
    Lanteri-Minet, Michel
    Schwedt, Todd J.
    Malkowski, Jean-Pierre
    Sodha, Monisha
    Walda, Susann
    Aronsson, Anne
    Laflamme, Annik
    Vo, Pamela
    CEPHALALGIA, 2017, 37 : 370 - 371
  • [25] Real-world patient perspective on the burden and impact of migraine
    de la Torre, Elena Ruiz
    Martelletti, Paolo
    Craven, Audrey
    Walsh, Donna
    Evans, Simon
    Dumas, Paula
    Diener, Hans-Christoph
    Lanteri-Minet, Michel
    Schwedt, Todd J.
    Malkowski, Jean-Pierre
    Sodha, Monisha
    Walda, Susann
    Aronsson, Anne
    Laflamme, Annik
    Vo, Pamela
    JOURNAL OF HEADACHE AND PAIN, 2017, 18
  • [26] Effectiveness and tolerability of monoclonal antibodies targeting CGRP pathway for migraine prevention: Real-world data from the Migraine Registry (ReMig) in the Czech Republic
    Nezadal, T.
    Dolezal, T.
    Pejrilova, D.
    Turkova, B.
    Markova, J.
    Bartkova, A.
    Klecka, L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [27] Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
    Siersbaek, Nikolaj
    Kilsdal, Laerke
    Jervelund, Christian
    Antic, Sonja
    Bendtsen, Lars
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 1 - 2
  • [28] Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
    Nikolaj Siersbæk
    Lærke Kilsdal
    Christian Jervelund
    Sonja Antic
    Lars Bendtsen
    BMC Neurology, 23
  • [29] Real-world evidence on the economic implications of CGRP-mAbs as preventive treatment of migraine
    Siersbaek, Nikolaj
    Kilsdal, Laerke
    Jervelund, Christian
    Antic, Sonja
    Bendtsen, Lars
    BMC NEUROLOGY, 2023, 23 (01)
  • [30] Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data
    Sanchez-Rodriguez, Carmen
    Gago-Veiga, Ana Beatriz
    Garcia-Azorin, David
    Guerrero-Peral, Angel Luis
    Gonzalez-Martinez, Alicia
    CURRENT PAIN AND HEADACHE REPORTS, 2024, 28 (12) : 1265 - 1272
12345